On January 5, 2021 PharmaEssentia Corporation (TPEx: 6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, reported its plans to present at the 39th Annual J.P. Morgan Healthcare Conference via webcast (Press release, PharmaEssentia, JAN 5, 2021, View Source [SID1234573507]). Meredith Manning, PharmaEssentia’s U.S. General Manager, is scheduled to present on Monday, January 11, 2021 at 10:25 a.m. Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!